Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability

Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability

Curtis D Collins1, Sarah Cookinham2, Jeannina Smith21Department of Pharmacy Services, 2Department of Medicine, Division of Infectious Disease, University of Michigan Health System, Ann Arbor, MI, USAAbstract: Oropharyngeal candidiasis is a very common localized infection of the mucus membranes of th...

Full description

Bibliographic Details
Main Authors:	Cookinham S, Collins CD, Smith J
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-07-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/management-of-oropharyngeal-candidiasis-with-localized-oral-miconazole-a7899

Similar Items

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Queiroz-Telles Flávio, et al.
Published: (2001-01-01)

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Flávio Queiroz-Telles, et al.

The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial.
by: Zhimin Yan, et al.
Published: (2016-01-01)

Preparation and Pharmaceutical Evaluation of Miconazole Nitrate Mucoadhesive Films for Vaginal Candidiasis
by: Rahim Bahri Najafi, et al.
Published: (2013-02-01)

Experience of using the local combination product containing miconazole and metronidazole for the treatment of bacterial vaginosis and vulvovaginal candidiasis in pregnant women
by: V O Bitsadze, et al.
Published: (2016-12-01)

Role of posaconazole in the treatment of oropharyngeal candidiasis
by: Voichita Ianas, et al.
Published: (2010-06-01)

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
by: Jose A Vazquez
Published: (2010-04-01)

The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy
by: Payal K. Patel, et al.
Published: (2012-01-01)

Oropharyngeal Candidiasis as a Presenting Symptom of Crohn’s Disease
by: Muhammad Sharif, et al.
Published: (2020-04-01)

Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses.
by: Marc Swidergall, et al.
Published: (2017-01-01)

Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran
by: Fariba Berenji, et al.
Published: (2015-03-01)

Predicting and evaluating outcome in oropharyngeal candidiasis (OPC) in AIDS
by: Hood, Stephen Victor
Published: (2000)

Effect of Butoconazole Nitrate 2% Vaginal Cream and Miconazole Nitrate 2% Vaginal Cream Treatments in Patients with Vulvovaginal Candidiasis
by: Myra A. Lappin, et al.
Published: (1996-01-01)

Nanoemulsions as novel nanocarrieres for drug delivery across the skin: In-vitro, in-vivo evaluation of miconazole nanoemulsions for treatment of Candidiasis albicans
by: Umar Farooq, et al.
Published: (2021-01-01)

Features of the Course of the Upper Gastrointestinal Tract Pathology in Patients with Oropharyngeal Candidiasis
by: I.V. Kushnirenko
Published: (2016-04-01)

Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis
by: Dolores R. Serrano, et al.
Published: (2019-08-01)

Conventional and alternative antifungal therapies to oral candidiasis
by: Paula Cristina Anibal, et al.
Published: (2010-12-01)

Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
by: Yu SY, et al.
Published: (2019-04-01)

Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis
by: Anna R. Huppler, et al.
Published: (2015-07-01)

Beta-Defensin 3-Mediated Regulation of Transcriptional Changes During Oropharyngeal Candidiasis
by: White, Cole Jacob
Published: (2018)

The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis
by: Norma V. Solis, et al.
Published: (2017-03-01)

Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran
by: Samira Salari, et al.
Published: (2018-12-01)

Tratamento da Tinea pedis com Miconazole em pacientes de ambulatório Treatment of Tinea pedis outpatientes with Miconazole
by: J. Martins de Barros, et al.
Published: (1972-09-01)

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad, et al.
Published: (2012-07-01)

Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.
by: Swetha Tati, et al.
Published: (2016-03-01)

The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis
by: Martinna Bertolini, et al.
Published: (2019-09-01)

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad DMD, MSc, et al.
Published: (2012-04-01)

Emergence of Azoles Resistance Candida species in Iranian AIDS defined patients with oropharyngeal candidiasis
by: Farzad Katiraee, et al.
Published: (2015-09-01)

Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis
by: Satutya Wicaksono, et al.
Published: (2020-10-01)

The Role of Antimicrobial Peptide Murine Beta Defensin-3 in Protection against Oropharyngeal Candidiasis
by: Mengesha, Bemnet Gashawbeza
Published: (2017)

Immunology of oral candidiasis
by: Janardhanam Dineshshankar, et al.
Published: (2014-01-01)

Development of Dermal Films Containing Miconazole Nitrate
by: Magdalena Bîrsan, et al.
Published: (2018-07-01)

Process Studies of Miconazole Nitrate (Antifugal Agent)
by: Hu, Po-Sheng, et al.
Published: (1996)

Species distribution and <it>in vitro </it>antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
by: Rijs Antonius JMM, et al.
Published: (2008-08-01)

Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis
by: Birhan Moges, et al.
Published: (2016-01-01)

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
by: Elena Roselletti, et al.
Published: (2019-07-01)

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.
by: Wen-Ze Qiu, et al.
Published: (2017-01-01)

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis
by: Shamala Gopal Rajadurai, et al.
Published: (2021-08-01)

In Vitro Antifungal Activity of Allium Hirtifolium in Comparison With Miconazole
by: Manijheh Motevallian, et al.
Published: (2010-05-01)

Laboratory Diagnosis of Oral Candidiasis
by: J Dinakar, et al.
Published: (2010-01-01)